RxDoctor Payments Data

William Tutrone, MD

Procedural Dermatology · Southamption, NYNPI 1861643611

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 251 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations.

$5,659in general payments, 2019–2025

Across 251 payments — averaging $22.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$757
  • Johnson & Johnson$727
  • AbbVie$724
  • Amgen$471
  • Lilly USA, LLC$442
  • Incyte Corporation$366
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$5,659100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,659 in reported general payments places this provider in the 60th percentile of 69 procedural dermatology providers in New York.

See all procedural dermatology providers in New York

Medicare billing

Part B allowed, 2024
$1,480,081
Medicare patients
898
Services billed
4,458

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin851$9,154
Fluorouracil56$4,562
Clobetasol Propionate48$2,678
Ammonium Lactate104$2,632
Ketoconazole74$1,924
Triamcinolone Acetonide25$1,650
Cefadroxil148$1,564
Desonide23$1,548
Fluocinonide15$1,399
Metronidazole20$1,222
CiclopiroxCiclopirox Olamine16$666
Clindamycin Phosphate22$584
Cephalexin52$356
Ciprofloxacin Hcl18$145
Clindamycin Hcl20$84

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Southamption

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →